Current status of the application of botulinum toxin as a treatment option for trigeminal neuralgia
- 24 December 2020
- journal article
- editorial
- Published by Taylor & Francis in Cranio®
- Vol. 39 (1) , 1-3
Abstract
Trigeminal neuralgia (TN) is known as one of the most common disorders in craniofacial pain, often known by the term “suicide disorder,” due to its great psychological impact on those who suffer fr...Keywords
This publication has 19 references indexed in Scilit:
- Toxina botulínica en la neuralgia del trigéminoMedicina Clinica, 2017
- The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analysesBritish Dental Journal, 2016
- Antinociceptive Effects of Botulinum Toxin Type A on Trigeminal Neuropathic PainJournal of Dental Research, 2016
- Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trialsThe Journal of Headache and Pain, 2016
- Botulinum Toxin Treatment of Neuropathic PainSeminars in Neurology, 2016
- Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trialTrials, 2015
- OnabotulinumtoxinA for trigeminal neuralgia: a review of the available dataArquivos de Neuro-Psiquiatria, 2015
- Botulinum toxin A in the treatment of trigeminal neuralgiaInternational Journal of Neuroscience, 2015
- Therapeutic effect of Botulinum toxin-A in 88 patients with Trigeminal Neuralgia with 14-month follow-upThe Journal of Headache and Pain, 2014
- A new treatment paradigm for trigeminal neuralgia using botulinum toxin type aThe Laryngoscope, 2013